Prostate Cancer
Conditions
Brief summary
The purpose of this single institution pilot study is to determine the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient portal. The investigators will assess patient compliance and satisfaction with eVisit follow up care in lieu of in person clinic visits.
Detailed description
Telehealth offers the opportunity to transform cancer surveillance into a patient-centered effort with shared leadership between patient and oncologist. Peer-to-peer electronic communications can improve the collaboration between oncologist and primary care provider (PCP) as patients transition back to primary care as their primary health provider. The investigators propose to test a patient-centered eHealth surveillance program utilizing novel asynchronous telehealth tools to provide patient-reported outcome symptom monitoring using the electronic medical record's patient portal (eVisit).
Interventions
OTHEReVisit
electronic surveillance program in lieu of in-person clinic visit
Sponsors
Duke University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ≥ 18 years old with histologically confirmed prostate cancer * Completed curative intent treatment to the prostate +/- pelvis * Deemed to be without evidence of active disease by treating provider with at least 1 follow up visit 3 or more months after treatment completion * MyChart account or willingness to open account * Access to the internet
Exclusion criteria
* Documented extrapelvic metastases * PSA meeting definition of recurrence (\>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) and rising with doubling time less than 1 year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of patients who complete all scheduled eVisits at the end of follow-up | 12 months | Defined as completion of labwork and at least 80% of the questions asked at each eVisit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| eVisit participant reported satisfaction | 12 months | Reported as the summary score from validated Brief Patient Satisfaction 10-item scale instrument assessed from 1/strongly agree through 5/strongly disagree |
| Number of participants with cancer treatment related toxicities | 12 months | Defined specifically as CTCAE Grade 2 or higher GI, GU, hormonal, and sexual toxicities |
| Feasibility of enrollment to the eVisit program | 12 months | Defined as the percentage of patients who are approached for eVisit and ultimately enroll |
| Financial impact of the eVisit program on participants compared to in person follow up clinic visits | 12 months | Defined by the financial burden assessment completed by participants, scored from 0/not at all through 4/very much |
| Financial impact of the eVisit program on Duke University Hospital (institution) compared to in person follow up | 12 months | Defined by percentage of participants/eVisits covered by insurance |
| Number of eVisit participants with cancer recurrence | 12 months | Defined as biochemical progression (PSA \>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) or metastasis (by imaging) |
Countries
United States
Outcome results
None listed